You are here

  • Home
  • Archive
  • Volume 3, Issue 1
  • Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RA

Citation Tools

Article menu

This article has a correction. Please see:

Download PDFPDF

Epidemiology
Original article
Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RA

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Jani M, Dixon WG, Kersley-Fleet L, et al
Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RA
RMD Open 2017;3:e000314. doi: 10.1136/rmdopen-2016-000314